{"created":"2023-07-27T06:55:54.700188+00:00","id":52386,"links":{},"metadata":{"_buckets":{"deposit":"67db804c-4f11-4d31-8afe-d2fea3247882"},"_deposit":{"created_by":18,"id":"52386","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"52386"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00052386","sets":["2812:2813:3929"]},"author_link":["72104","44580"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-07-15","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"11p.","bibliographicVolumeNumber":"2016 – 2019","bibliographic_titles":[{"bibliographic_title":"令和1(2019)年度 科学研究費補助金 国際共同研究加速基金(国際共同研究強化) 研究成果報告書"},{"bibliographic_title":"2019 Fiscal Year Final Research Report","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"211Atは核医学治療への応用が期待されるα放射体の一つであるが、半減期が短いためその利用は製造拠点に限られている。本研究では遠隔地での211Atを用いた研究を支援するための211Rn/211Atジェネレータ作成のために、米国アルゴンヌ国立研究所および、211Atの臨床経験のある米国デューク大学との共同研究として211Rnの製造実験と高放射能の211Atを用いた有機溶媒の放射線分解に関する影響を評価した。検討の結果、タンデム型加速器ATLASでの211Rnの製造を確認した。また硝酸溶液から有機溶媒へ高放射能の211Atを抽出する場合、放射線分解に起因する現象は見られなかった。","subitem_description_type":"Abstract"},{"subitem_description":"211At is one of the α-emitters expected to be applied to radionuclide therapy in a field of nuclear medicine, but its use is limited to manufacturing sites because of its short half-life. In this study, 211Rn was manufactured in collaboration with Argonne National Laboratory and Duke University in the United States, which has clinical experience with 211At, in order to create a 211Rn/211At generator to support studies using 211At in remote areas. Under the collaboration work, we tried to manufacture the 211Rn by using 6Li beam of the tandem accelerator ATLAS. And we also evaluated the effects of the radiolysis in organic solvents using high activity 211At. As a result, we confirmed the production of 211Rn at Argone National Laboratory. Moreover, when extracting highly radioactive 211At from nitric acid solution to organic solvent, no phenomenon due to radiolysis was observed.","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:15KK0301, 研究期間(年度):2016 – 2019","subitem_description_type":"Other"},{"subitem_description":"出典：「物質の三態を制御したRn/Atジェネレータの開発とα線内用療法への展開 (国際共同研究強化)」研究成果報告書　課題番号15KK0301\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所））\n（https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-15KK0301/15KK0301seika/)を加工して作成","subitem_description_type":"Other"}]},"item_9_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"福島県立医科大学 / 金沢大学医薬保健研究域保健学系","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00058680","subitem_identifier_reg_type":"JaLC"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/search/?qm=80313675"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/search/?qm=80313675","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15KK0301/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15KK0301/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-15KK0301/15KK0301seika/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-15KK0301/15KK0301seika/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-05-10"}],"displaytype":"detail","filename":"ME-PR-WASHIYAMA-K-kaken 2020-13p.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"ME-PR-WASHIYAMA-K-kaken 2020-13p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/52386/files/ME-PR-WASHIYAMA-K-kaken 2020-13p.pdf"},"version_id":"4b2207c0-cf9d-45cb-a335-388a02e57af8"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"物質の三態を制御したRn/Atジェネレータの開発とα線内用療法への展開 (国際共同研究強化)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"物質の三態を制御したRn/Atジェネレータの開発とα線内用療法への展開 (国際共同研究強化)"},{"subitem_title":"Development of a matter phase controlled Rn/At generator for targeted alpha therapy(Fostering Joint International Research)","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["3929"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-05-10"},"publish_date":"2021-05-10","publish_status":"0","recid":"52386","relation_version_is_last":true,"title":["物質の三態を制御したRn/Atジェネレータの開発とα線内用療法への展開 (国際共同研究強化)"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T14:08:53.193153+00:00"}